Reduced Risk of Synovial Sarcoma in Females
Author Information
Author(s): Bu X, Bernstein L, Brynes R K
Primary Institution: University of Southern California, Keck School of Medicine
Hypothesis
We hypothesize that X-chromosome inactivation reduces the likelihood of synovial sarcoma development in females.
Conclusion
The study provides evidence that X-inactivation may explain the similar risk of synovial sarcoma in females compared to males.
Supporting Evidence
- The incidence of synovial sarcoma is roughly one per million adults.
- More than 95% of synovial sarcoma cases demonstrate a characteristic t(X;18) translocation.
- The male-to-female ratio of age-standardised incidence rates is 1.1:1.
- The observed proportion of male cases was 53.3%, which aligns with the hypothesis of X-inactivation.
Takeaway
This study suggests that girls and women are less likely to get a certain type of cancer because one of their X-chromosomes is turned off.
Methodology
The study analyzed age-specific and sex-specific incidence data from the SEER program for 680 cases of synovial sarcoma.
Potential Biases
The study acknowledges potential ascertainment bias from non-population-based case series.
Limitations
The study did not analyze data according to race or geographical region due to limited case numbers.
Participant Demographics
Data derived from SEER registries, representing about 14% of the US population.
Statistical Information
P-Value
p<0.00001
Statistical Significance
p<0.00001
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website